Skip to main content

Redx raises £10m

Redx raises £10m

Liverpool-headquartered drug developer Redx Pharma has raised £10m before expenses through a share placing. The business said that the major part of the net proceeds would be used to progress its pipeline and further develop other assets in immune-oncology, infection and immunology.

Neil Murray, chief executive of Redx, said: “We are delighted to have successfully raised these new funds with approximately half coming from new institutional investors and also with very strong support from our existing shareholders.”

See the article in full at InsiderMedia.com